Growth hormone regulates neuroendocrine responses to weight loss via AgRP neurons.
Agouti-Related Protein
/ genetics
Animals
Body Weight
/ drug effects
Brain
/ drug effects
Energy Metabolism
/ drug effects
Female
Growth Hormone
/ metabolism
Human Growth Hormone
/ analogs & derivatives
Leptin
/ metabolism
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Receptors, Somatotropin
/ genetics
Weight Loss
/ drug effects
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
08 02 2019
08 02 2019
Historique:
received:
15
05
2018
accepted:
10
12
2018
entrez:
10
2
2019
pubmed:
10
2
2019
medline:
9
4
2019
Statut:
epublish
Résumé
Weight loss triggers important metabolic responses to conserve energy, especially via the fall in leptin levels. Consequently, weight loss becomes increasingly difficult with weight regain commonly occurring in most dieters. Here we show that central growth hormone (GH) signaling also promotes neuroendocrine adaptations during food deprivation. GH activates agouti-related protein (AgRP) neurons and GH receptor (GHR) ablation in AgRP cells mitigates highly characteristic hypothalamic and metabolic adaptations induced by weight loss. Thus, the capacity of mice carrying an AgRP-specific GHR ablation to save energy during food deprivation is impaired, leading to increased fat loss. Additionally, administration of a clinically available GHR antagonist (pegvisomant) attenuates the fall of whole-body energy expenditure of food-deprived mice, similarly as seen by leptin treatment. Our findings indicate GH as a starvation signal that alerts the brain about energy deficiency, triggering key adaptive responses to conserve limited fuel stores.
Identifiants
pubmed: 30737388
doi: 10.1038/s41467-019-08607-1
pii: 10.1038/s41467-019-08607-1
pmc: PMC6368581
doi:
Substances chimiques
Agouti-Related Protein
0
Leptin
0
Receptors, Somatotropin
0
Human Growth Hormone
12629-01-5
Growth Hormone
9002-72-6
pegvisomant
N824AOU5XV
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
662Subventions
Organisme : NIA NIH HHS
ID : R01 AG059779
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
J Biol Chem. 2012 May 25;287(22):17942-50
pubmed: 22474325
J Clin Endocrinol Metab. 2003 Oct;88(10):4776-80
pubmed: 14557454
Temperature (Austin). 2017 May 26;4(3):258-291
pubmed: 28944270
JAMA. 1999 Oct 27;282(16):1568-75
pubmed: 10546697
Cell Metab. 2017 Jul 5;26(1):24-26
pubmed: 28648981
Endocrinology. 2014 Mar;155(3):840-53
pubmed: 24424063
Neuron. 2017 Aug 16;95(4):757-778
pubmed: 28817798
Elife. 2018 Mar 12;7:
pubmed: 29528284
J Clin Invest. 2011 Apr;121(4):1424-8
pubmed: 21364278
N Engl J Med. 1995 Mar 9;332(10):621-8
pubmed: 7632212
J Clin Invest. 2003 May;111(9):1409-21
pubmed: 12727933
Am J Physiol. 1980 Nov;239(5):E379-84
pubmed: 7001924
Science. 1996 Dec 6;274(5293):1704-7
pubmed: 8939859
Mol Cell Endocrinol. 2014 Apr 5;386(1-2):34-45
pubmed: 24035867
Cell Metab. 2013 Jul 2;18(1):21-8
pubmed: 23823475
Science. 1963 May 31;140(3570):987-8
pubmed: 13975313
J Neurosci. 2010 Feb 17;30(7):2472-9
pubmed: 20164331
PLoS One. 2015 Aug 14;10(8):e0135502
pubmed: 26275221
Eur J Endocrinol. 2003 Apr;148 Suppl 2:S21-5
pubmed: 12670297
J Clin Endocrinol Metab. 1998 Feb;83(2):382-95
pubmed: 9467546
Cell Metab. 2014 Dec 2;20(6):1030-7
pubmed: 25470549
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7467-72
pubmed: 20231469
Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7239-44
pubmed: 9207075
Mol Metab. 2018 Feb;8:1-12
pubmed: 29289646
J Clin Endocrinol Metab. 1996 Jul;81(7):2460-7
pubmed: 8675561
Nature. 1996 Jul 18;382(6588):250-2
pubmed: 8717038
Endocrinology. 1993 Jan;132(1):224-34
pubmed: 8380374
J Clin Invest. 2011 Jan;121(1):355-68
pubmed: 21183787
J Neurosci. 2014 Jul 23;34(30):9982-94
pubmed: 25057200
Mol Metab. 2018 Aug;14:130-138
pubmed: 29914853
Int J Obes Relat Metab Disord. 2002 Apr;26(4):504-9
pubmed: 12075577
J Clin Invest. 1998 Jul 1;102(1):153-64
pubmed: 9649569
J Clin Endocrinol Metab. 2002 May;87(5):2391-4
pubmed: 11994393
Eur J Endocrinol. 2011 Aug;165(2):249-54
pubmed: 21602313
Mol Endocrinol. 2013 Mar;27(3):524-35
pubmed: 23349524
Brain Struct Funct. 2017 Jan;222(1):341-363
pubmed: 27072946
J Clin Invest. 2005 Dec;115(12):3579-86
pubmed: 16322796
Endocrinology. 2016 Oct;157(10):3901-3914
pubmed: 27471877
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3155-60
pubmed: 22232663
Compr Physiol. 2016 Mar 15;6(2):687-735
pubmed: 27065166
J Clin Invest. 2012 Mar;122(3):1000-9
pubmed: 22326958
Endocr J. 1998 Apr;45 Suppl:S19-26
pubmed: 9790225
Cell. 1998 May 29;93(5):841-50
pubmed: 9630227
J Clin Endocrinol Metab. 2000 Nov;85(11):4003-9
pubmed: 11095423